Register entry
Boehringer Ingelheim Fremont, Inc.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 15
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Boehringer Ingelheim Fremont, Inc. | 6701 Kaiser Drive, Fremont, California (CA) 94555, United States (USA) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3005925062967820619 |
Catalogue
Drug listings by form and route
1515 active NDC listings: 9 drug for further processing, 6 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 9, BULK INGREDIENT 6.
| Dosage form | NDCs |
|---|---|
| liquid | 15 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| boehringer ingelheim fremont, inc. | 15 |
Catalogue
Marketed products
15| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Adalimumab | liquid | 83012-009DRUG FOR FURTHER PROCESSING |
| - | Adalimumab | liquid | 83012-011DRUG FOR FURTHER PROCESSING |
| - | Adalimumab | liquid | 83012-012DRUG FOR FURTHER PROCESSING |
| - | Adalimumab | liquid | 83012-013DRUG FOR FURTHER PROCESSING |
| - | Adalimumab | liquid | 83012-045DRUG FOR FURTHER PROCESSING |
| - | Adalimumab | liquid | 83012-046DRUG FOR FURTHER PROCESSING |
| - | Aflibercept | liquid | 83012-052DRUG FOR FURTHER PROCESSING |
| - | Cyltezo | liquid | 83012-035BULK INGREDIENT |
| - | Cyltezo | liquid | 83012-036DRUG FOR FURTHER PROCESSING |
| - | Cyltezo | liquid | 83012-037BULK INGREDIENT |
| - | Cyltezo | liquid | 83012-038DRUG FOR FURTHER PROCESSING |
| - | Enhertu | liquid | 83012-020BULK INGREDIENT |
| - | Patritumab | liquid | 83012-021BULK INGREDIENT |
| - | Pembrolizumab | liquid | 83012-010BULK INGREDIENT |
| - | Zenocutuzumab | liquid | 83012-023BULK INGREDIENT |
Neighbours
Registered in the same town
2- Alexza Pharmaceuticals, Inc.Fremont, CA
- Citragen Pharmaceuticals IncFremont, CA
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Boehringer Ingelheim Fremont, Inc. FDA approved?
- Boehringer Ingelheim Fremont, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Boehringer Ingelheim Fremont, Inc.'s drugs manufactured?
- The FDA register lists Fremont, CA. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
- What drugs does Boehringer Ingelheim Fremont, Inc. make?
- 15 products are listed under Boehringer Ingelheim Fremont, Inc. in the openFDA NDC Directory, most often as liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.